Cat.No. : |
Spike-214V
Optional Service: Optional requirements on this protein
|
Product Overview : |
Recombinant COVID-19 S protein RBD ((N354D, D364Y), Arg319-Phe541) was fused to His-tag at the C-terminus and expressed in human 293 cells (HEK293). |
Description : |
It's been reported that COVID-19 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Source : |
HEK293 |
Species : |
COVID-19 |
Tag : |
His |
Predicted N Terminal : |
Arg319 |
Form : |
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4, 10% trehalose. |
Molecular Mass : |
The protein has a calculated MW of 27.0 kDa. The protein migrates as 33-35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. |
Protein length : |
Arg319-Phe541 |
Endotoxin : |
Less than 1.0 EU per μg by the LAL method. |
Purity : |
>95% as determined by SDS-PAGE. |
Storage : |
For long term storage, the product should be stored at lyophilized state at -20 centigrade or lower. Please avoid repeated freeze-thaw cycles. This product is stable after storage at: -20 to -70 centigrade for 12 months in lyophilized state; -70 centigrade for 3 months under sterile conditions after reconstitution. |
Reconstitution : |
It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4ºC before opening to recover the entire contents. |
SDS-PAGE of Spike-214V : |
COVID-19 S protein RBD (N354D, D364Y), His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
|
Bioactivity-ELISA of Spike-214V : |
Immobilized Human ACE2, Fc Tag at 2 μg/mL (100 μL/well) can bind COVID-19 S protein RBD (N354D, D364Y), His Tag with a linear range of 2-63 ng/mL (QC tested).
Immobilized COVID-19 S protein RBD (N354D, D364Y), His Tag at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-COVID-19-S protein RBD Antibody, Human IgG1 with a linear range of 0.2-6 ng/mL (Routinely tested).
Immobilized COVID-19 S protein RBD (N354D, D364Y), His Tag at 2 μg/mL (100 μL/well) can bind Anti-COVID-19 Neutralizing Antibody, Human IgG1 with a linear range of 0.195-6.25 ng/mL (Routinely tested).
|
Bioactivity-SPR of Spike-214V : |
Human ACE2, Fc Tag captured on CM5 chip via anti-human IgG Fc antibodies surface can bind COVID-19 S protein RBD (N354D, D364Y), His Tag with an affinity constant of 7.57 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
|
Bioactivity-BLI of Spike-214V : |
Loaded Human ACE2, Fc Tag on Protein A Biosensor, can bind COVID-19 S protein RBD (N354D, D364Y), His Tag with an affinity constant of 6.32 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
|